AGILENT TECHNOLOGIES, INC. Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment
AGILENT TECHNOLOGIES, INC. (A) reported Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment of $0 for the 12-month period ending 2018-10-31, per its 10-K filed 2018-12-20.
Discontinued › Income Statement › Other Income
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments · last filed 2018-12-20
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2017-10-31 was $0.00.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2017-07-31 was $0.00.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2017-04-30 was $0.00.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for the quarter ending 2017-01-31 was $0.00, a 100.00% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2018 was $0.00.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2016 was $15.00M.
- AGILENT TECHNOLOGIES, INC. defined benefit plan, net periodic benefit cost (credit), gain (loss) due to curtailment for fiscal 2015 was $0.00.
| Period end | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 3 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 6 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 9 month | Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment 12 month |
|---|---|---|---|---|
| 2018-10-31 | $0.00 10-K · filed 2018-12-20 | |||
| 2017-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-20 | $0.00 derived: sum of 2 quarters · filed 2018-12-20 | $0.00 derived: sum of 3 quarters · filed 2018-12-20 | $0.00 10-K · filed 2018-12-20 |
| 2017-07-31 | $0.00 10-Q · filed 2017-09-06 | $0.00 derived: sum of 2 quarters · filed 2017-09-06 | $0.00 10-Q · filed 2017-09-06 | $0.00 derived: sum of 4 quarters · filed 2018-12-20 |
| 2017-04-30 | $0.00 10-Q · filed 2017-06-06 | $0.00 10-Q · filed 2017-06-06 | $0.00 derived: sum of 3 quarters · filed 2018-12-20 | $0.00 derived: sum of 4 quarters · filed 2018-12-20 |
| 2017-01-31 | $0.00 10-Q · filed 2017-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-12-20 | $0.00 derived: sum of 3 quarters · filed 2018-12-20 | $0.00 derived: sum of 4 quarters · filed 2018-12-20 |
| 2016-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-20 | $0.00 derived: sum of 2 quarters · filed 2018-12-20 | $0.00 derived: sum of 3 quarters · filed 2018-12-20 | $15.00M 10-K · filed 2018-12-20 |
| 2016-07-31 | $0.00 10-Q · filed 2017-09-06 | $0.00 derived: sum of 2 quarters · filed 2017-09-06 | $15.00M 10-Q · filed 2017-09-06 | |
| 2016-04-30 | $0.00 10-Q · filed 2017-06-06 | $15.00M 10-Q · filed 2017-06-06 | ||
| 2016-01-31 | $15.00M 10-Q · filed 2017-03-08 | |||
| 2015-10-31 | $0.00 10-K · filed 2017-12-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |